The Journal of Practical Medicine ›› 2024, Vol. 40 ›› Issue (13): 1827-1832.doi: 10.3969/j.issn.1006-5725.2024.13.011
• Clinical Research • Previous Articles Next Articles
Yapeng LIANG1,Chaopu ZHANG2,Hao ZHANG1,Zhongqun. WANG2
Received:
2024-01-29
Online:
2024-07-10
Published:
2024-07-09
CLC Number:
Yapeng LIANG,Chaopu ZHANG,Hao ZHANG,Zhongqun. WANG. The relationship between the expression of serum ANGPTL8 and KLF2 and the degree of coronary artery disease and the occurrence of major adverse cardiac events in patients with acute myocardial infarction[J]. The Journal of Practical Medicine, 2024, 40(13): 1827-1832.
Tab.1
Comparison of general data of patients with AMI in mild group and severe group"
组别 | 例数 | 性别(男/女) | 年龄(岁) | BMI(kg/m2) | 吸烟史[例(%)] | 饮酒史[例(%)] | 高血压史[例(%)] |
---|---|---|---|---|---|---|---|
轻度组 | 52 | 27/25 | 51.86 ± 10.64 | 23.65 ± 3.58 | 18(34.62) | 20(38.46) | 16(30.77) |
重度组 | 54 | 29/25 | 53.04 ± 9.85 | 24.01 ± 3.75 | 21(38.89) | 22(40.74) | 31(57.41) |
χ2/t/Z值 | 0.034 | 0.848 | 0.675 | 0.208 | 0.058 | 7.617 | |
P值 | 0.854 | 0.399 | 0.501 | 0.648 | 0.810 | 0.006 |
Tab.3
Influencing factors analysis of the degree of coronary artery disease in patients with AMI"
自变量 | β | SE | Wald χ2 | P值 | OR | 95%CI |
---|---|---|---|---|---|---|
高血压史 | 0.977 | 0.412 | 5.626 | 0.018 | 2.657 | 1.185 ~ 5.958 |
高血脂史 | 1.417 | 0.534 | 7.044 | 0.008 | 4.126 | 1.449 ~ 11.751 |
HDL-C | -0.472 | 0.216 | 4.767 | 0.029 | 0.624 | 0.409 ~ 0.953 |
cTnI | 1.639 | 0.623 | 6.918 | 0.009 | 5.148 | 1.518 ~ 17.456 |
ANGPTL8 | 1.607 | 0.515 | 9.732 | 0.002 | 4.986 | 1.817 ~ 13.681 |
KLF2 | -0.759 | 0.362 | 4.399 | 0.036 | 0.468 | 0.230 ~ 0.951 |
常量 | -1.682 | 0.246 | 46.750 | < 0.001 | 0.186 |
1 |
GULATI R, BEHFAR A, NARULA J, et al. Acute myocardial infarction in young individuals[J]. Mayo Clin Proc, 2020, 95(1):136-156. doi:10.1016/j.mayocp.2019.05.001
doi: 10.1016/j.mayocp.2019.05.001 |
2 |
黎德恩, 梅啸, 李明琰. 急性ST段抬高型心肌梗死患者直接经皮冠脉介入治疗术后住院期间发生心力衰竭的危险因素[J]. 实用医学杂志, 2021, 37(13): 1674-1683. doi:10.3969/j.issn.1006
doi: 10.3969/j.issn.1006 |
3 |
CHYRCHEL M, GALLINA T, JANUSZEK R, et al. The Reduction of Left Ventricle Ejection Fraction after Multi-Vessel PCI during Acute Myocardial Infarction as a Predictor of Major Adverse Cardiac Events in Long-Term Follow-Up[J]. Int J Environ Res Public Health, 2022, 19(20):13160. doi:10.3390/ijerph192013160
doi: 10.3390/ijerph192013160 |
4 |
FAN Z Y, WU C W, WESEMANN L D, et al. Clin Radiol. Predictive value of major adverse cardiac events by T2-mapping texture analysis of the myocardial remote zone in patients with acute myocardial infarction[J]. Clin Radiol, 2022, 77(3):e241-e249. doi:10.1016/j.crad.2021.12.015
doi: 10.1016/j.crad.2021.12.015 |
5 | 何涛, 丁安. 血清骨硬化蛋白和血管生成素样蛋白8水平与高血压患者颈动脉内膜中层厚度的相关性[J]. 中华高血压杂志, 2022, 30(6):562-566. |
6 |
黄欣欣, 应燕萍. Kruppel样因子2与心血管疾病的研究进展[J]. 中国比较医学杂志, 2022, 32(2):94-98,132. doi:10.3969/j.issn.1671-7856.2022.02.014
doi: 10.3969/j.issn.1671-7856.2022.02.014 |
7 |
中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南(2019)[J]. 中华心血管病杂志, 2019, 47(10):766-783. doi:10.3760/cma.j.issn.0253-3758.2019.10.003
doi: 10.3760/cma.j.issn.0253-3758.2019.10.003 |
8 |
YOKOKAWA T, YOSHIHISA A, KIKO T, et al. Residual Gensini Score Is Associated With Long-Term Cardiac Mortality in Patients With Heart Failure After Percutaneous Coronary Intervention[J]. Circ Rep, 2020, 28(2):89-94. doi:10.1253/circrep.cr-19-0121
doi: 10.1253/circrep.cr-19-0121 |
9 |
冯凯歌, 王新全, 杨怡, 等. 心肌梗死后心力衰竭的诊疗进展[J]. 实用医学杂志, 2022, 38(8): 923-928. doi:10.3969/j.issn.1006-5725.2022.08.002
doi: 10.3969/j.issn.1006-5725.2022.08.002 |
10 |
HENRY T D, TOMEY M I, TAMIS-HOLLAND J E, et al. Invasive management of acute myocardial infarction complicated by cardiogenic shock: A Scientific Statement From the American Heart Association[J]. Circulation, 2021, 143(15):e815-e829. doi:10.1161/cir.0000000000000959
doi: 10.1161/cir.0000000000000959 |
11 | CHOI Y, LEE K Y, KIM S H, et al. Predictors for early cardiac death after discharge from successfully treated acute myocardial infarction[J]. Front Med (Lausanne), 2023, 15(10):1165400. |
12 |
QIN Y, YAN G, QIAO Y, et al. Relationship between random blood glucose, fasting blood glucose, and Gensini score in patients with acute myocardial infarction[J]. Biomed Res Int, 2019, 2019:9707513. doi:10.1155/2019/9707513
doi: 10.1155/2019/9707513 |
13 |
LI X T, FANG H, LI D, et al. Association of platelet to lymphocyte ratio with in-hospital major adverse cardiovascular events and the severity of coronary artery disease assessed by the Gensini score in patients with acute myocardial infarction[J]. Chin Med J (Engl), 2020, 133(4):415-423. doi:10.1097/cm9.0000000000000650
doi: 10.1097/cm9.0000000000000650 |
14 | SIMSEK B, INAN D, CINAR T, et al. Evaluation of low-density lipoprotein cholesterol target attainment rates according to the 2016 and 2019 European Society of Cardiology/European Atherosclerosis Society Dyslipidemia Guidelines for secondary prevention in patients with acute myocardial infarction[J]. Rev Invest Clin, 2021, 73(3):371-378. |
15 | Blood Pressure Lowering Treatment Trialists' Collaboration. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis[J]. Lancet, 2021, 397(10285):1625-1636. |
16 |
SHEN T, YANG X, ZHANG Z. Positive relationship of RDW with NT-proBNP and cTnI in acute myocardial infarction patients[J]. Clin Lab, 2022, 68(6): 35704727. doi:10.7754/clin.lab.2021.210808
doi: 10.7754/clin.lab.2021.210808 |
17 |
JIAO X, HE J, YANG Y, et al. Associations between circulating full-length angiopoietin-like protein 8 levels and severity of coronary artery disease in Chinese non-diabetic patients: a case-control study[J]. Cardiovasc Diabetol, 2018, 17(1):92. doi:10.1186/s12933-018-0736-6
doi: 10.1186/s12933-018-0736-6 |
18 |
FADAEI R, SHATERI H, DISTEFANO J K, et al. Higher circulating levels of ANGPTL8 are associated with body mass index, triglycerides, and endothelial dysfunction in patients with coronary artery disease[J]. Mol Cell Biochem, 2020, 469(1/2):29-39. doi:10.1007/s11010-020-03725-7
doi: 10.1007/s11010-020-03725-7 |
19 |
MA Z, WEI K, YANG F, et al. Tumor-derived exosomal miR-3157-3p promotes angiogenesis, vascular permeability and metastasis by targeting TIMP/KLF2 in non-small cell lung cancer[J]. Cell Death Dis, 2021, 12(9):840. doi:10.1038/s41419-021-04037-4
doi: 10.1038/s41419-021-04037-4 |
20 |
CHEN G H, LI X L, DENG Y Q, et al. The molecular mechanism of EPO regulates the angiogenesis after cerebral ischemia through AMPK-KLF2 signaling pathway[J]. Crit Rev Eukaryot Gene Expr, 2019, 29(2):105-112. doi:10.1615/critreveukaryotgeneexpr.2019029018
doi: 10.1615/critreveukaryotgeneexpr.2019029018 |
21 |
CHEN S, CHEN X, LUO Q, et al. Retinoblastoma cell-derived exosomes promote angiogenesis of human vesicle endothelial cells through microRNA-92a-3p[J]. Cell Death Dis, 2021, 12(7):695. doi:10.1038/s41419-021-03986-0
doi: 10.1038/s41419-021-03986-0 |
22 |
DAI Y, YAN T, GAO Y. Silence of miR-32-5p promotes endothelial cell viability by targeting KLF2 and serves as a diagnostic biomarker of acute myocardial infarction[J]. Diagn Pathol, 2020, 15(1):19. doi:10.1186/s13000-020-00942-y
doi: 10.1186/s13000-020-00942-y |
23 |
GAO C, QIAN H, SHI Q, et al. MicroRNA-363-3p serves as a diagnostic biomarker of acute myocardial infarction and regulates vascular endothelial injury by targeting KLF2[J]. Cardiovasc Diagn Ther, 2020, 10(3):421-430. doi:10.21037/cdt-19-700
doi: 10.21037/cdt-19-700 |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||